ISBT/Bio-Rad Webinars-Could it be drugs? How to differentiate AIHA from DIIHA

Aim of the Webinar

This webinar focuses on recognizing serologic results in warm and cold autoimmune hemolytic anemia (AIHA) and understanding how these results may obscure drug-induced immune hemolytic anemia (DIIHA). Participants will learn methods to distinguish between these conditions.

Learning Objectives

1. Understand Serologic Patterns: Analyze serologic characteristics in warm AIHA and cold agglutinin disease.
2. Identify Diagnostic Clues: Evaluate antibody identification and direct antiglobulin test (DAT) results that suggest alternative diagnoses beyond warm or cold autoantibodies.
3. Utilize Patient History: Recognize the importance of patient medication and transfusion history when interpreting a positive DAT.
4. Confirm Drug-Dependent Antibodies: Review specialized testing methods to confirm the presence of drug-dependent antibodies.

Educational Level

Intermediate to advanced (Levels 3, 4, and 5).

Prior Knowledge Required

Participants should have a basic understanding of:

• Biological characteristics of warm and cold AIHA.
• Standard serologic workups in autoimmune hemolytic anemia.

Target Audience

• Medical Laboratory Scientists/Biomedical Scientists
• Immunohematology Reference Lab Scientists
• Physicians

Speaker

Susan T. Johnson
Director, Versiti Blood Center of Milwaukee, Wisconsin, USA

Moderator

Arnaud Reggiani
Scientific Affairs, Clinical Diagnostics, Bio-Rad Laboratories

CTA: Watch the webinar to gain advanced insights into autoimmune hemolytic anemia diagnosis and management!